The Voluntary HIV-1 Counseling and Testing Efficacy Study was designed to measure the efficacy of HIV VCT in developing country and resource poor settings where access to antiretrovirals and other expensive medications is difficult or impossible.
The National Institutes of Health’s Fogarty International Center in collaboration with a number of other agencies sponsored the Fogarty Workshop on International HIV/AIDS Prevention Research Opportunities on April 18-20, 1998. The AIDS Research Institute at the University of California, San Francisco hosted the Workshop.
This forum grew out of an interest in having dialogues between researchers, providers and community members (these categories are not mutually exclusive groups). This would serve the dual purpose of giving research legs so that it can inform programs and helping ensure that program and life experience inform research studies.
Another factor for calling this meeting was the high prevalence of HIV among men who have sex with men and are also injection drug users (MSM IDUs).
This monograph is based largely on presentations and discussion at the June, 1999 policy forum Primary HIV Prevention: Designing Effective Programs for People Living with HIV. The Forum was hosted by the AIDS Research Institute at UCSF and the National Association of People with AIDS. The Forum was sponsored by the National Institute of Mental Health (NIMH), the NIH Office of AIDS Research (OAR), and the Centers for Disease Control and Prevention (CDC).
When the latest HIV prevalence consensus report was released in San Francisco in 1997, statistics revealed increasing HIV rates among gay and bisexual men of color. Among gay men of color, Latinos had the highest rates of HIV infection. In response to this, the STOP AIDS Project decided to heighten their HIV prevention efforts for Latino gay and bisexual men.
STOP AIDS convened a meeting for all of the agencies in San Francisco providing HIV prevention services for Latino gay and bisexual men.
In an effort to equip community and institutional leaders from the health professions with the skills and knowledge to sustain community-campus partnerships, we are pleased to provide you with a copy of Partnership Perspectives-a magazine designed to foster greater awareness of critical issues impacting upon partnerships between communities and health professions schools.
¿Qué necesítan los afro-americanos en la prevención del VIH? (revisado 8/00)
¿corren el riesgo de contraer el VIH los afro-americanos?
Sí. Muchos Afro-Americanos corren alto riesgo de infectarse con VIH, no por razones étnicas o raciales, sino por los comportamientos de riesgo en los que pueden estar participando.
What Are Deaf Persons’ HIV Prevention Needs?
Are deaf persons at risk for HIV?
Yes. It is estimated that 7,000 to 26,000 deaf persons in the US are infected with HIV.1 However, the Centers for Disease Control and Prevention (CDC) does not currently collect information on deafness and HIV or AIDS. Maryland was the first state to include questions about deafness in its HIV counseling and testing forms.
¿Qué necesítan los sordos en la prevención del VIH?
¿están a riesgo de contraer el VIH?
Si. Se estima que en los EEUU existen de 7,000 a 26,000 personas carentes del sentido auditivo infectadas con el VIH.1 Sin embargo, los Centros para el Control de Enfermedades (CDC por sus siglas en Inglés) actualmente no recopilan información acerca de los que padecen de sordera y VIH o SIDA.
What Are African-Americans’ HIV Prevention Needs?
revised 9/99
Are African-Americans at risk for HIV?
Yes. Many African-Americans are at high risk for HIV infection, not because of their race or ethnicity, but because of the risk behaviors they may engage in.
¿Qué necesitan los adolescentes en la prevención del VIH?
¿pueden contraer los adolescentes el VIH?
Desafortunadamente, sí. Los casos de infección del VIH se incrementan más aceleradamente en los jóvenes. La mitad de todos los casos de VIH se presentan en personas menores de 25 años. De todos los casos de VIH de 1994-1997 en jóvenes de 13-24 años, 44% eran mujeres y 63% Afro-Americanos.
What Are Adolescents’ HIV Prevention Needs?
Can adolescents get HIV?
Unfortunately, yes. HIV infection is increasing most rapidly among young people. Half of all new infections in the US occur in people younger than 25. From 1994 to 1997, 44% of all HIV infections among young people aged 13-24 occurred among females, and 63% among African-Americans.
Can Healthcare Workers Help in HIV Prevention?
revised 4/99
Are healthcare providers important in prevention?
Yes. Healthcare providers have many opportunities to help foster the behavior changes needed to stem the spread of HIV infection. In the US in 1996, the average adult visited a physician 3 times a year.
Más de un millón de personas en los EEUU se inyectan drogas con frecuencia, con un alto costo a la sociedad de más de 50 billones de dólares al sector salud, pérdidas de productividad, accidentes y crímenes. Quienes se inyectan drogas se exponen a contraer el VIH o la hepatitis arriesgando así su propia salud, la de las personas con las que comparten agujas/jeringas, sus parejas sexuales y sus descendientes.
¿Sirve el intercambio de jeringas?
(revisado 4/99)
¿por qué es necesario el intercambio de agujas/jeringas?
Más de un millón de personas en los EEUU se inyectan drogas con frecuencia, con un alto costo a la sociedad de más de 50 billones de dólares al sector salud, pérdidas de productividad, accidentes y crímenes.1 Quienes se inyectan drogas se exponen a contraer el VIH o la hepatitis arriesgando así su propia salud, la de las personas con las que comparten agujas/je
More than a million people in the US inject drugs frequently, at a cost to society in health care, lost productivity, accidents, and crime of more than $50 billion a year. People who inject drugs imperil their own health. If they contract HIV or hepatitis, their needle-sharing partners, sexual partners and offspring may become infected. It is estimated that half of all new HIV infections in the US are occurring among injection drug users (IDUs).
Does HIV Needle Exchange Work?
revised 12/98
Why do we need needle exchange?
More than a million people in the US inject drugs frequently, at a cost to society in health care, lost productivity, accidents, and crime of more than $50 billion a year.1 People who inject drugs imperil their own health.
In June 1996, the Center for AIDS Prevention Studies published the second occasional paper in this monograph series, entitled Sustaining Support for Domestic HIV Vaccine Research: Social Issues Over the Long Haul of Human Trials. Authored by Chris Collins, the research was supported by grants from the National Institute of Mental Health, National Institutes of Health and the University of California, San Francisco. This new report is intended to function as an update to the 1996 monograph.
